Ocugen Inc. [NASDAQ: OCGN] closed the trading session at $0.31 on 11/20/20. The day’s price range saw the stock hit a low of $0.3011, while the highest price level was $0.3417. The company report on November 6, 2020 that Ocugen Provides Business Update and Third Quarter 2020 Financial Results.
First Gene Therapy Candidate OCU400 On Track to Enter the Clinic in 2021.
Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness diseases, reported third quarter 2020 financial results along with a general business update.
The stocks have a year to date performance of -40.02 percent and weekly performance of 8.22 percent. The stock has been moved at -5.34 percent over the last six months. The stock has performed -2.53 percent around the most recent 30 days and changed -23.93 percent over the most recent 3-months.
If compared to the average trading volume of 7.90M shares, OCGN reached to a volume of 22826873 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Ocugen Inc. [OCGN]:
The Average True Range (ATR) for Ocugen Inc. is set at 0.02, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 1212.69. The Price to Book ratio for the last quarter was 3.12, with the Price to Cash per share for the same quarter was set at 0.12.
OCGN stock trade performance evaluation
Ocugen Inc. [OCGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.22. With this latest performance, OCGN shares dropped by -2.53% in over the last four-week period, additionally sinking by -5.34% over the last 6 months – not to mention a rise of 0.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OCGN stock in for the last two-week period is set at 56.02, with the RSI for the last a single of trading hit 58.35, and the three-weeks RSI is set at 50.18 for Ocugen Inc. [OCGN]. The present Moving Average for the last 50 days of trading for this stock 0.3121, while it was recorded at 0.3023 for the last single week of trading, and 0.3492 for the last 200 days.
Ocugen Inc. [OCGN]: An insightful look at the core fundamentals
Ocugen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
Earnings per share (EPS) analysis for Ocugen Inc. [OCGN] stock
With the latest financial reports released by the company, Ocugen Inc. posted 4.13/share EPS, while the average EPS was predicted by analysts to be reported at -0.14/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3,050.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OCGN.
Ocugen Inc. [OCGN]: Insider Ownership positions
There are presently around $4 million, or 13.10% of OCGN stock, in the hands of institutional investors. The top three institutional holders of OCGN stocks are: VANGUARD GROUP INC with ownership of 7,437,567, which is approximately 2158.016% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 5,018,690 shares of the stock with an approximate value of $1.57 million in OCGN stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.17 million in OCGN stock with ownership of nearly 171.877% of the company’s market capitalization.
13 institutional holders increased their position in Ocugen Inc. [NASDAQ:OCGN] by around 12,223,819 shares. Additionally, 8 investors decreased positions by around 1,377,539 shares, while 3 investors held positions by with 232,096 shares. The mentioned changes placed institutional holdings at 13,833,454 shares, according to the latest SEC report filing. OCGN stock had 4 new institutional investments in for a total of 107,348 shares, while 6 institutional investors sold positions of 845,069 shares during the same period.